Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,876 | -141,752 | -102,988 | -65,713 | -32,066 |
| Depreciation Amortization | -4,763 | -2,053 | -625 | 90 | 87 |
| Accounts receivable | 1,029 | 50 | 138 | -786 | -209 |
| Accounts payable and accrued liabilities | 464 | -307 | -84 | -539 | 746 |
| Other Working Capital | -3,723 | -1,176 | 7,112 | -747 | -688 |
| Other Operating Activity | 8,325 | 21,984 | 14,316 | 9,460 | 2,742 |
| Operating Cash Flow | $-39,544 | $-123,254 | $-82,131 | $-58,235 | $-29,388 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -191,803 | -401,076 | -181,244 | -115,975 | N/A |
| PPE Investments | -530 | -2,703 | -2,334 | -1,843 | -955 |
| Investing Cash Flow | $-192,333 | $-403,779 | $-183,578 | $-117,818 | $-955 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 56,052 | 595,094 | 90,280 | 15,930 | 349 |
| Other Financing Activity | -3,253 | -32,892 | -3,412 | -1,172 | -226 |
| Financing Cash Flow | $52,799 | $562,202 | $86,868 | $14,758 | $123 |
| Beginning Cash Position | 292,423 | 257,254 | 257,254 | 257,254 | 257,254 |
| End Cash Position | 113,345 | 292,423 | 78,413 | 95,959 | 227,034 |
| Net Cash Flow | $-179,078 | $35,169 | $-178,841 | $-161,295 | $-30,220 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,544 | -123,254 | -82,131 | -58,235 | -29,388 |
| Capital Expenditure | -530 | -2,703 | -2,334 | -1,843 | -955 |
| Free Cash Flow | -40,074 | -125,957 | -84,465 | -60,078 | -30,343 |